Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
about
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccinesNetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets.HIV-1 Vpu Mediates HLA-C Downregulation.Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.Characterization of the Antigen Processing Machinery and Endogenous Peptide Presentation of a Bat MHC Class I Molecule.Specificity of inhibitory KIRs enables NK cells to detect changes in an altered peptide environment.Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects.HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.Improved Prediction of Bovine Leucocyte Antigens (BoLA) Presented Ligands by Use of Mass-Spectrometry-Determined Ligand and in Vitro Binding Data.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
P2860
Q33610621-127D2D65-430D-4CE1-B43D-98ECB2A8B239Q36742441-4ED6167A-F294-424B-9C00-57737133E36EQ36997294-ED33F312-6AEC-43F2-BEB2-9322615639A6Q37253013-5087BE29-818F-4107-982E-EA6222A3B0BBQ40105709-560DE16D-6BBE-4A15-8828-5619897DBC7CQ40127990-CF38369C-ECD9-4CCA-BFCA-1F899EA86242Q40188529-BF76B749-3D2A-4045-AFE2-54E888DAE3B9Q40348395-9CEA4226-9AB3-4994-8528-96BE9DF7F4B4Q46265999-693E61C9-A82D-4573-9026-6E92EA48983BQ46722989-B300A915-18D3-4563-BB01-AA9C45EC5CD0Q49836890-79BAC08C-2D7E-4536-BF3B-5DFFBC125F05Q54204994-2C0268A9-8E7A-471B-93E7-0D465CC43EF7Q58214193-272DAE01-7061-40EA-9F54-7C7F23841B16
P2860
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@ast
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@en
type
label
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@ast
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@en
prefLabel
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@ast
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@en
P2093
P2860
P50
P356
P1476
Defining the HLA class I-assoc ...... om HIV-1-infected human cells.
@en
P2093
Anuska Llano
Christian Brander
Hongbing Yang
Lucy Dorrell
Manuel Crespo
Nadine L Dudek
Philip D Charles
Samandhy Cedeño
Thomas Partridge
Tomáš Hanke
P2860
P356
10.1002/EJI.201545890
P407
P50
P577
2015-10-15T00:00:00Z